| 产品详情 |
| Edit |   |
|---|
| Product Name | DQP 1105 |
|---|
| Description | Noncompetitive NMDA receptor antagonist; displays over 50-fold selectivity for GluN2D- and GluN2C-containing receptors over GluN2B-, GluK2-, GluA1- and GluN2A-containing receptors (IC50 values are 2.7, 8.5, 121, 153, 198 and 206 μM, respectively). Reduces frequency of channel opening. Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions. Purity 97%. MW (observed): 558.42 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-pyrazole-1-butanoic acid |
|---|
| Gene, Accession, CAS # | CAS: 380560-89-4 |
|---|
| Catalog # | 4491/50 |
|---|
| Price | |
|---|
| Order / More Info | DQP 1105 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25081057 |
|---|
| 产品资料 |
|
|